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Abstract The aim of this study is to summarize published
empirical data describing the predictors of adhering to
screening practices and choosing to have prophylactic
surgery in women at increased risk for breast and ovarian
cancer. Pubmed, Psychinfo and Cinahl databases were
searched to identify studies on the predictors of adherence
to breast and ovarian cancer screening and predictors of
having a prophylactic mastectomy or salpingo-oophorec-
tomy. We found 37 empirical studies that met our inclusion
criteria. The main predictors of the use of preventive
measures are related to DNA test results, socio-demo-
graphic characteristics, and psychological outcome
measures. It is concluded that there is no unequivocal
relationship between age, education, risk perception, or
anxiety and adherence to breast and ovarian cancer
screening practices. Worrying about cancer is associated
with a higher adherence to screening practices.
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Abbreviations
BPM Bilateral prophylactic mastectomy
BSE Breast self examination
FDR First-degree relative
PM Prophylactic mastectomy
CPM Contralateral prophylactic mastectomy
BPSO Bilateral prophylactic salpingo-oophorectomy
Introduction
Breast cancer is one of the most important causes of death
in women and those with a family history of breast cancer
are at increased risk of the disease [54]. The risk is two to
three times higher in women who have a first-degree rel-
ative (FDR) with breast cancer [13], or even higher if the
relative had bilateral premenopausal breast cancer or breast
cancer under the age of 40 years [48], when compared with
women who have no family history of breast cancer.
Increasingly, women at familial risk for breast cancer are
being targeted for cancer prevention and monitoring. It is
estimated that of all breast cancer patients, 5–10% carry
inherited autosomal dominant mutations [25]. Hereditary
breast cancer is also strongly associated with the occur-
rence of ovarian cancer in a family and with multiple cases
of breast cancer, particularly if these were cases of early-
onset [42].
Since the identification of two breast cancer suscepti-
bility genes, BRCA1 and BRCA2, genetic testing has been
incorporated into the practice of oncology [42]. Mutations
in the BRCA1 and BRCA2 genes are associated with an
increased risk for breast and ovarian cancer [5]. When a
woman is identified as a mutation carrier, specific screen-
ing practices and/or prophylactic surgery become options
to consider [10]. To detect early development of cancer in
women at high risk for breast cancer, it is important that
they are alert to suspicious symptoms, that they perform
frequent self-examination of their breasts (BSE), and that
they have regular mammography or breast MRI and
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clinical breast examinations (secondary prevention) [42].
Screening for ovarian cancer includes semi-annual trans-
vaginal ultrasound and CA–125 measurement [10]. Some
women opt for prophylactic surgery (primary prevention)
to prevent the development of cancer; it seems to reduce
the risk of breast and ovarian cancer developing [15, 37].
Earlier studies have shown that women at risk for breast
cancer often do not adhere to the recommended guidelines
for a monthly breast self-examination [24] or mammo-
graphic screening [30], and that women with comparable
risks for cancer may vary greatly in whether they opt to
have prophylactic surgery or not [38, 50, 51]. In the near
future, more women will be identified as carriers of a
BRCA1 or BRCA2 mutation and will therefore know they
carry a high risk gene for breast and ovarian cancer. From a
preventive point of view, it is important to know what
factors will influence their adherence to screening advice
and their individual decisions on whether to have prophy-
lactic mastectomy (PM) and/or bilateral prophylactic
salpingo-oophorectomy (BPSO). Such information can be
used to optimize the advice given on self- or clinical-
examination, to urge women to adhere to the advice given,
and to provide support regarding a decision to undergo
prophylactic surgery.
This review systematically summarizes the published
empirical data describing the predictors of adhering to
screening practices and choosing to have prophylactic




We searched Pubmed, Psychinfo and Cinahl to identify
relevant articles published in English between 1990 and
June 2006 The following search terms were combined:
prophylactic treatment, cancer concern, adherence, com-
pliance, breast cancer, ovarian cancer, BRCA*,
uncertainty, psychological, cancer screening, screening
behavi*, surveillance, risk perception and genetic risk.
Additional sources of articles were references cited in
identified papers.
Selection of eligible papers
All the abstracts identified by the search were assessed by
two of the authors independently and any discrepancies
were discussed. The selected full articles were indepen-
dently coded for eligibility by two raters using data
extraction sheets. The two raters agreed on the articles to
include in the study. Papers were only included if they
covered women with a family history of breast or ovarian
cancer and a clearly described elevated cancer risk, and if
they were empirical studies on:
(1) predictors of breast and ovarian cancer screening
(2) predictors of the use of PM and BPSO
We excluded abstracts of presentations, book chapters,
single-page comments, papers about pre-symptomatic
DNA-testing, predictors or decisions of genetic testing,
intentions to have genetic testing, intentions to have
screening and prophylactic treatment, or genetic screening,
and reviews, case reports about patients or families,
community studies about the use of screening practices,
and studies with a purely qualitative study design.
Papers eligible for this review are presented separately
with regard to breast or ovarian cancer screening practices
and the choice for prophylactic surgery, and are ranked as
much as possible by the risk status of the participating
women. Only significant predictors are described. Studies
concerning participants who were tested for a BRCA
mutation, or who had a family history indicative for a
BRCA mutation (e.g. at least 2 FDRs with breast or ovarian
cancer) were viewed as covering a high-risk population.
Studies concerning participants with at least one FDR with
a diagnosis of breast or ovarian cancer were viewed as
covering a population at moderately increased risk (e.g.
cumulative life-time risk of breast cancer \30%, and of
ovarian cancer \10%).
Results
Using the specific search terms, we identified 37 articles
meeting the inclusion criteria (Tables 1–3). Twenty of the
37 selected studies used a prospective design with a follow-
up between 6 months and 5 years, although most of the
studies had a follow-up of 1 year or less.
Participants were mainly unaffected women at moder-
ately increased risk for breast and/or ovarian cancer. The
study population consisted completely or largely of breast
cancer patients in only three studies [19, 50, 51], whereas
in two other studies a small proportion of the participants
had a prior history of breast cancer [31, 32]. BRCA
mutation carriers were included in 11 studies [7, 19, 28, 33,
36, 46, 49, 50, 51, 58, 59].
Predictors of the adherence to screening for breast
cancer
Twenty-five studies examined possible predictors of
adherence to breast cancer screening (Table 1) and
screening behavior: in particular, the influence of being a
BRCA1/2 mutation carrier [7, 28, 33, 46], of
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socio-demographic and psychological variables like risk
perception, psychological distress, coping strategies [26],
and worry about cancer [1, 9, 14, 22, 27, 34].
Socio-demographic variables
Age There are inconsistent results regarding the influence
of age on adherence to screening practices for breast can-
cer. Some studies found a higher adherence to
mammography screening in older women [1, 14, 29, 32,
39, 46, 59], whereas other studies showed older women to
have a lower adherence [12, 22, 39].
In a prospective study to determine the level of partici-
pation to cancer surveillance before and after genetic
counseling, Lux et al. [32] found that older women at high
risk for breast cancer, more frequently participated in self-
palpation, breast ultrasound and mammography prior to
consultation. After consultation, high risk women more
frequently used breast ultrasound and mammography. They
also found that older women with lower risk more frequently
used mammography before and after consultation [32].
In their prospective study, Peshkin et al. [46] examined
the use of breast cancer screening in a clinically based
sample of 107 women after BRCA1/2 testing. They showed
that only 39% of a younger group of carriers (25–39 years)
had mammography compared to 74% of a group of carriers
who were older than 40 years. Factors independently
associated with mammography use included age (older than
40 years) and DNA test result. Non-carriers had very good
adherence to general population screening guidelines.
In studies of women at moderate risk for breast cancer,
Lerman et al. [29] found that age was associated with better
adherence to mammography using a cross-sectional and a
prospective design [28]. In a longitudinal study in 213
unaffected women, Diefenbach [14] studied the relation-
ship between psychological variables at baseline and
subsequent screening behavior. Cancer worry and older age
were significant predictors of mammography adherence.
Four studies found a negative association between age
and adherence to screening for breast cancer [12, 17, 22, 41].
In a cross-sectional study of 216 unaffected women with a
strong family history of breast cancer, Isaacs et al. [22]
found that both younger (40-) and older women (50+) had
mammography performed less frequently. Meiser et al. [39]
found older women (30+) to be more vigilant with respect to
mammography recommendations than younger women.
Erblich et al. (2000) found a younger age to be associated
with underperformance of breast self-examination (BSE)
[17]. In a cross-sectional study of a group of women at
moderate risk for breast cancer, Daly et al. [12] found that
there was a greater disparity between objective risk factors
and screening behavior in women older than 50 years.
Civil Status In two studies, civil status has been shown
to be associated with better adherence to screening





Study design Main predictorsd
Use of CA125 Ultrasound use
Isaacs et al. [22] 216 1 Cross-sectional FHe +; Jewish ancestry + FH +; risk perception +
Risk perception and
objective OCf risk +
Jewish ancestry +
Tinley et al. [58] 293 1 Retrospective 9 Recommendation by physician +, risk
perception +, education +, support +
Andersen et al. [1] 164 1.2 Retrospective 9 9
Andersen et al. [2] 286 1.2 Cross-sectional FH +; cancer worry + 9
Lynch et al. [33] 459 1 Prospective BRCA1/2 carrier + BRCA1/2 carrier +
Meiser et al. [38] 95 1.2 Cross-sectional 9 Age +, [2 affected relatives +




Schwartz et al. [52] 121 1.2 Cross-sectional FH +, cancer worry + Employment status +, cancer worry +
a Only significant predictors are mentioned
b N, number of participants used for the analyses
c Studies are ordered according to risk status: 1, high risk (e.g. tested for BCRA mutation or family history indicative for BRCA mutation); 2,
moderately increased risk (e.g. 1 FDR with breast or ovarian cancer
d ‘-’, negative effect; ‘+’, positive effect
e FH, family history of ovarian cancer
f OC, Ovarian cancer
g BC, Breast cancer
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practices [12, 58]. Tinley et al. found being married was
associated with adherence to mammography guidelines
[58], while Daly found being either married or single were
associated with adherence to mammography [12] com-
pared to being divorced or widowed.
Education In several studies about predictors of breast
cancer screening, higher education is related to higher
mammography adherence [12, 27]. However, Meiser et al.
[40] found lower education to be associated to more vigi-
lance to screening practices (mammography, BSE and
clinical breast examination) in a group of 218 unaffected
women who were at increased risk for breast cancer. A
lower level of education was also found to be associated to
excessive breast self-examination [16].
Disease-related variables
Family history of breast cancer Several studies showed that
having a family history of breast cancer was associated with
better adherence to mammography[3, 20, 31, 58]. Studying
the influence of familial risk on the age of uptake of early
cancer detection facilities, Lux et al. [31] found that
patients without breast cancer participated at an earlier time
in all methods of early cancer detection than patients with a
history of breast cancer. They concluded that familial risk
can influence patient’s behaviour in relation to early cancer
detection facilities and result in a younger age of uptake of
nearly all methods of early cancer detection facilities.
In bivariate analyses, Andersen et al. found that family
history was a significant predictor of mammography use in
a large cross-sectional study. However, it did not remain
significant after adjusting for age and worry [3]. Prospective
study designs have shown being a carrier of a BRCA1/2
mutation to be associated with better adherence to
mammography and BSE [7, 28].
Lynch et al. [33] evaluated the adherence to cancer
prevention recommendations in women with known BRCA
mutations before and after BRCA mutation disclosure.
They found that the rate of compliance with both breast and
ovarian cancer screening recommendations was signifi-
cantly increased among mutation carriers following result
disclosure. Among noncarriers, the rate of compliance with
breast cancer screening was significantly increased.
Risk perception Risk perception (e.g. the perception of
one’s own risk of developing breast cancer) has often been
studied in association with adherence to screening for
breast cancer. The results are not unequivocal, with some
studies showing a positive association [16, 20, 32], two






Study design Main predictorsb
Prophylactic mastectomy (PM) Bilateral Prophylactic
salpingo oophorectomy
(BPSO)
Botkin et al. [7] 189 1 Prospective BRCA1/2 carrier +
Evans et al. [19] 158 1 Retrospective Tumor stage +, having a FDR with BC +
Lerman et al. [28] 216 1 Prospective BRCA1/2 carrier - BRCA1/2 carrier -
Scheuer et al. [49] 251 1 Prospective Age - Age +,
Descriptive FH +c Personal history BC +d
Schwartz et al. [51] 79 1 Prospective BRCA1/2 carrier +, physicians
recommendations +
Risk perception +
Meijers-Heijboer et al. [36] 68 1 Prospective BRCA1/2 carrier + Being a carrier +
Parenthood +, age - Age +
Antill et al. [4] 182 1.2 Retrospective Number of relatives died from BC +, perceived
cancer risk -, age -, BRCA1/2 carrier +
Perceived cancer risk -
FH +, fibrocystic breasts +
Meiser et al. [38] 95 1.2 Cross sectional Cancer worry + Cancer anxiety +
Stefanek et al. [55] 164 1.2 Prospective Cancer worry +, risk perception +,
previous breast biopsy +
Schwartz et al. [51] 289 1.2 Prospective FH +,
Tiller et al. [57] 95 1.2 Prospective Attitude +, age +
a Risk status, 1, high-risk (e.g. tested for BRCA mutation or family history indicative for BRCA mutation; 2, moderately increased risk (e.g. 1
FDR with breast or ovarion cancer)
b main predictors: ‘-’, negative effect; ‘+’, positive effect
c FH, family history of breast/ovarian cancer
d BC, Breast cancer
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studies showing a negative association [24, 43], and other
studies finding no relationship [3, 12, 52].
In three studies, a positive association was found
between risk perception and adherence to screening prac-
tices for breast cancer. Hailey et al. [20] examined the
impact of having a first degree relative (FDR) with breast
cancer on women who were not involved in a formal breast
cancer prevention program. Women with a FDR had more
negative attitudes about breast cancer (including more
anxiety) than women without a FDR, thought they had a
greater risk of getting breast cancer (although they under-
estimated their true risk), and were more likely to engage in
appropriate screening behavior. A higher perceived risk of
breast cancer was associated with better mammography use
for all women, regardless of whether they had a FDR.
In a large cross-sectional study of 1053 unaffected
women with at least one FDR with breast cancer, Epstein
et al. [16] examined which demographic and psychological
factors were associated with excessive BSE performance.
Excessive BSE was more common in older women of
African-American descent, who were less well educated
and more likely to have an affected daughter and more than
2 affected FDRs. Ethnicity, perceived risk of breast cancer,
and frequency of thoughts about breast cancer were also
independently significantly associated with excessive BSE.
They concluded that women identified as excessive self-
examiners should be educated about the proper frequency
of BSE and told that more frequent practice does not
improve the efficacy of this technique.
In the studies by Kash et al. [24] and Neise et al. [43], a
negative association was found between risk perception
and adherence to screening practices. Kash et al. [24]
studied the beliefs of women at high risk for breast cancer
about their risk of getting breast cancer and the impact of
this information on their surveillance behaviors and psy-
chological distress. However, women with a sense of
personal efficacy regarding early detection of breast cancer
also engaged more frequently in general preventive health
care behaviors. Women who perceived their risk as high,
were more anxious, felt they could do little about devel-
oping breast cancer, and were less compliant with
surveillance and other preventive behaviors. Being at high
risk may not be a reason to start surveillance behaviors, but
may in fact increase a woman’s fears and thus act as a
deterrent. Kash et al. [24] found negative linear relation-
ships between anxiety and BSE, and between perceived
risk and BSE [24].
In a study among 129 women with a moderate family
history of breast cancer, Neise et al. [43] found that the
majority of women either over-estimated (52%) or under-
estimated (24%) their personal risk despite prior genetic
counseling. Women who thought they had a high risk
underwent the recommended screening significantly less
often than women with a low risk perception. Daly et al.
[12] and Andersen et al. [1] did not find any association
between risk perception and screening practices. In a cross-
sectional study, Daly et al. [12] examined the relationship
between the accuracy of the perceived risk and prior breast
cancer screening behavior in a group of 969 women with a
moderate risk for breast cancer: reported mammography
adherence was only associated with having had a breast
biopsy.
Andersen et al. [1] performed a study to examine the
association between the perception of high risk for ovarian
cancer and the use of breast and ovarian cancer-screening.
They found that rates of mammography screening were
low among women with a high or average risk perception.
Although women with a high risk perception reported high
levels of awareness of breast cancer, this did not spur them
to undergo additional screening.
Several studies showed over-performance of BSE to be
associated with more breast cancer specific distress [17,
59], though it is not possible to say whether there is a
specific causal relationship between over-performance of
BSE and distress.
Psychological variables
Worry about cancer Some studies found cancer worry to be
associated with better adherence to screening recommen-
dations [3, 9, 14, 34], but Isaacs’ study [22] of 216
unaffected women with a strong family history of cancer
found no association. In a study on mammography
screening in a cohort of 140 FDRs of breast cancer patients
[27], it was shown that worrying about breast cancer may
form a barrier to mammography adherence among high-
risk women, particularly those with less formal education.
In a cross-sectional study, Andersen et al. [1] examined
the association of worry about breast cancer with mam-
mography use in a large population-based sample stratified
on family history of breast cancer. In bivariate analyses,
family history proved to be a significant predictor of
mammography use. However, in the multivariate analyses
it was not significant after adjusting for age and worry,
which did remain as significant predictors for mammog-
raphy [3].
McCaul et al. [34] performed a prospective, longitudinal
study about breast cancer worry in 135 women with a
moderate family history. Women with a positive family
history reported more frequent worrying and distress than
those without. Baseline worry and intrusive thoughts were
positively associated with self-reported BSE behavior, but
trait anxiety did not predict BSE behavior.
Anxiety Anxiety level has been found to be associated
with both more [9, 17, 39, 43, 59] and less adherence to
BSE and clinical breast examination [24, 29], but another
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study found no influence of anxiety on adherence to
screening practices [7].
The studies of Kash et al. [24] and Lerman et al. [29]
found a negative association between anxiety and screen-
ing adherence. In Kash et al.’s [24] cross-sectional study,
women who perceived their risk as high, had high anxiety,
felt they could do little about developing breast cancer, and
were less compliant with BSE, clinical breast examination,
and other preventive behavior. They concluded that being
at high risk may increase a woman’s fears and thereby
deter surveillance behavior [24].
In a cross-sectional study, Lerman et al. [29] found that
younger women with a moderate family history of breast
cancer less frequently adhered to BSE and about one-third
of all women reported breast cancer worries. Psychological
distress was associated with non-adherence to mammog-
raphy, and with both infrequent and excessive BSE [29].
In a prospective study among 189 women at high risk for
breast cancer, Botkin et al. [7] did not find an association
of general and test-specific anxiety with mammog-
raphy adherence among mutation carriers at 2 years post-
testing.
In all the other studies mentioned, there was a positive
association found between anxiety and screening adher-
ence. In a cross-sectional study of 461 unaffected women
with a moderate risk for breast cancer, Meiser et al. [39]
examined breast cancer screening uptake and vigilance to
breast cancer screening recommendations and its socio-
demographic and psychosocial predictors. It was shown
that women’s psychological characteristics (Internal Health
Locus of Control and Anxiety) were more powerful pre-
dictors of BSE than objective breast cancer risk and socio-
demographic characters.
Brain et al. [9] examined the relationship between
anxiety and adherence to breast self-examination in a
group of 833 women with a moderate risk for breast
cancer. In their retrospective study they found that higher
levels of cancer-specific anxiety were associated with
higher rather than lower BSE frequency. This seemed to
be a function of greater subjective concern rather than
more extensive family history. They also found that
excessive self-examiners reported higher general anxiety.
In a study among 129 women with a moderate family
history, Neise et al. [43] found that highly anxious
women showed above-average participation in screening
programs.
Erblich et al. [17] found that over-performers of BSE
reported more cancer-related distress (intrusive breast
cancer thoughts and emotional upset during BSE) than
regular BSE performers and underperformers. In a pro-
spective design, Van Dooren et al. [59] found breast cancer
specific distress to be associated with BSE over-perfor-
mance in women younger than 40 years.
Predictors of the use of screening for ovarian cancer
Eight studies investigated predictors of ovarian cancer
screening and these are summarized in Table 2. The main
predictors are being a carrier of a BRCA1/2 mutation [33,
50], perceived risk [1, 22] cancer worries [2, 22, 52], age
[32, 38], the number of affected relatives [22, 38],
employment status [52] and Jewish ancestry [22].
Among carriers of a BRCA mutation, there was an
increased rate of compliance to ovarian cancer screening
compared to non-carriers [33] and women who received a
negative or uninformative DNA test result [50].
Isaacs et al. [22] performed a cross-sectional study in
216 unaffected women with a strong family history of
breast or ovarian cancer who were participating in a free
BRCA genetic counseling and testing program. They found
that only 20% of participants had ever had a CA-125
measurement performed, while 31% had had a pelvic or
abdominal ovarian ultrasound examination. Women with a
family history of ovarian cancer were much more likely to
undergo ovarian cancer screening. In their study, the per-
ceived and objective risks were independent predictors of
CA-125 measurements. They also found a positive asso-
ciation with Jewish ancestry and screening practices for
ovarian cancer, while having at least one relative with
ovarian cancer was strongly associated with ovarian cancer
screening. There were no associations between screening
behavior and cancer worries, or the number of relatives
with breast cancer, or income. They concluded that breast-
and ovarian-screening uptake in healthy women from
hereditary breast cancer families is suboptimal. Their
findings indicate a need for better education about
screening guidelines for high-risk women.
Andersen et al. [2] examined the association between
the perception of high risk for ovarian cancer and the
interest in the use of breast and ovarian cancer-screening.
High-risk women reported low levels of awareness of
ovarian cancer, so that ovarian cancer screening was seri-
ously under-used.
A study of female FDRs of patients with ovarian cancer,
showed that the use of ovarian cancer screening among
women at moderate risk was positively influenced by the
number of affected relatives, as well as by psychological
(cancer worries) and socio-demographic factors (employ-
ment status) [52].
Both Isaacs et al. [22] and Meiser et al. [38] found a
positive association between the number of relatives with
ovarian cancer and the screening uptake for ovarian cancer.
Meiser et al. [38] studied 95 unaffected women with a
moderate family history of breast or ovarian cancer who
had not had a DNA test: women with 2 or more affected
relatives were more likely to have ovarian ultrasound tests
than women with less than 2 affected relatives.
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Predictors of the use of prophylactic mastectomy
Predictors for prophylactic surgery are summarized in
Table 3. Indicators for choosing a (contralateral) prophy-
lactic mastectomy ((C)PM) are being a carrier of a
BRCA1/2 mutation [4, 19, 51], physician’s advice [51],
elevated cancer anxiety [38, 55], parenthood [36], and
number of affected relatives [4, 49].
Being a mutation carrier was significantly related to
patients’ surgical decision-making. Schwartz et al. [51]
studied a group of 194 newly diagnosed breast cancer
patients for the impact of genetic counseling and testing
on their surgical decision-making. In their study, 48% of
the identified carriers chose bilateral prophylactic mas-
tectomy (BPM) in contrast with only 24% of the patients
in whom no mutation was detected. Evans et al. [19]
found that contralateral breast cancer risk at the time of
diagnosis was the clearest indicator for choice to have
risk reducing CPM. They suggest that all women in the
highest risk categories should have the option of dis-
cussing the contralateral risk, genetic testing and their
options regarding surgery at the time of their initial breast
cancer diagnosis.
However, others show that unaffected carriers may not
opt for prophylactic surgery as only 3% of the unaffected
carriers had had a mastectomy one year after their test
result had been disclosed [28].
Young women with children opt for DNA testing and
PM especially, so that parenthood is a predictor of pro-
phylactic mastectomy [36].
Additional predictors of bilateral mastectomy included
patients’ self-reports of physician recommendations for
BRCA1/2 testing and BPM [51].
Several studies showed that elevated cancer worry or
cancer anxiety had a positive influence on opting for sur-
gery [38, 55]. Stefanek et al. [55] indicated that breast
cancer related worry may influence the selection for PM in
women (N = 164) with an elevated risk (at least one FDR
with breast cancer). Women who did not express interest in
surgery reported fewer biopsies and a lower subjective
breast cancer risk.
Antill et al. [4] found a significant association between
the uptake of BPM and number of relatives who had died
from breast cancer. Women who reported BPM gave a
lower estimation of their own cancer risk than those who
had not undertaken the procedure.
Predictors of the use of prophylactic
salpingo-oophorectomy
Factors other than anxiety are more powerful predictors for
the uptake of bilateral prophylactic salpingo-oophorectomy
(BPSO) in women with a strong family history (more than
two FDRs) with breast or ovarian cancer. Women’s attitude
about BPSO is a significant and useful indicator of actual
uptake, as is age. No significant association between cancer
worry and uptake was found, although anxiety was sig-
nificantly reduced after BPSO and women expressed a high
level of satisfaction with their decision [57].
There is a tendency among women to opt for a BPSO
rather than a BPM [7, 28, 36]. In a prospective study
(N = 500, 2 years follow-up) by Botkin et al. [7], the
response to interventions for early cancer prevention in
mutation carriers, non-carriers and women who did not
have a DNA test were compared. None of the carriers had
had a BPM 2 years after testing. Of carriers who were
25 years and older, 46% had obtained BPSO (including
78% of the women 40 years and older). Carriers preferred
prophylactic surgery to reduce their ovarian cancer risk to
other early detection measures.
In a study by Meijers-Heijboer et al. [36], 51% of 68
unaffected women with an identified mutation who were
eligible for prophylactic surgery opted for bilateral mas-
tectomy and 64% opted for BPSO. Age was significantly
associated with BPSO (older women were more likely to
opt for BPSO than younger women), but not with mas-
tectomy, although there was a tendency towards choosing
mastectomy at a younger age. Antill et al. [4] also showed
that women over 40 years and mutation carriers more
frequently chose for BPSO.
In the study by Lerman et al. [28] 13% of the carriers
had had a BPSO one year after learning of their test result
and 4.4% had chosen for BPM.
Scheuer et al. [49] found similar results. In a sample of
251 mutation carriers, women with PM were younger than
those not opting for surgery. Apart from that, women who
did not undergo preventive surgery showed an overall
increase in screening behavior. Women who opted for
BPSO had a stronger family history of ovarian cancer or
had a greater number of first- and second-degree relatives
with a prior breast cancer diagnosis.
Meiser et al. [38] demonstrated that women with high
cancer anxiety were significantly more likely to consider
BPSO. In a group of unaffected women with a strong
family history of breast and ovarian cancer (N = 95, no
DNA test), 12% had undergone a BPSO and 23% said they
would consider it if genetic testing indicated a mutation.
The consideration was positively related with increased
levels of cancer anxiety, but not with objective risk.
In a study by Schwartz et al. [50] among 297 high-risk
women who were offered free genetic counseling and
testing, having BPSO was independently predicted by
perceived (elevated) risk of ovarian cancer, and by a family
history of ovarian cancer: 27% of the mutation carriers and
2% of the non-carriers had BPSO in the year following
their testing.
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Discussion
The empirical studies covered in this review reveal several
predictors of the use of breast/ovarian cancer screening and
(contralateral) prophylactic mastectomy and bilateral sal-
pingo-oophorectomy ((C)PM, BPSO). The main predictors
are related to DNA test results, socio-demographic char-
acteristics, and psychological outcome measures.
Knowledge about the influence of these predictors may
help physicians in giving patient tailored information about
screening practices and the options of prophylactic surgery.
Screening for cancer
Several factors may influence a patient’s decision to start
regular surveillance. As expected, DNA test results predict
the use of screening. Among BRCA1/2 carriers there was
an increased use of CA-125, transvaginal ultrasound
screening, and mammography [7, 46, 50]. BSE (breast self-
examination) also increased in mutation carriers [7].
Uninformative or negative DNA test results do not lead to
increased ovarian cancer screening. However, non-carriers
may increase the frequency of their mammography screens
and BSE if recommendations for the general population are
discussed during genetic counseling, which suggests that
they are not falsely reassured by a negative genetic test
result [7, 46]. Apparently, good adherence to general
population screening guidelines can be achieved in women
from high-risk families who appear to be negative for the
BRCA mutation. When genetic testing is completed, cli-
nicians and geneticists could therefore be invited to discuss
the breast cancer screening recommendations for the gen-
eral population with the non-carriers.
It has recently been shown that surveillance for ovarian
cancer in women at high-risk has important limitations and
is very inefficient [35, 44]. For now, BPSO remains the
optimal risk-reducing strategy for women at high risk. This
implies that nowadays screening for ovarian cancer will not
be advocated in many hospitals, so uptake will vary in
different centres regardless of other variables.
In most studies selected for this review, cancer worry and
anxiety are positively related to breast and ovarian cancer
screening practices, suggesting that worry and anxiety are
not a barrier to using screening [2, 9, 14, 17, 34, 41, 43, 50,
52, 58]. In a meta-analysis about the relationship between
worry and screening behaviours Hay et al, concluded that in
most studies breast cancer worry is associated with a greater
likelihood of screening [21]. This conclusion holds regard-
less of how cancer worry is measured and whether the
screening outcome was mammography or BSE. They also
found that high levels of cancer worry are uncommon and
high levels of worry were not associated with reduced
screening. However, others have demonstrated that higher
anxiety was related to poor adherence to BSE and clinical
breast examination [24], particularly in women with less
formal education [30]. It can be concluded that in daily
clinical practice, clinicians should check whether women at
risk for breast/ovarian cancer have a high level of anxiety as
this may lead to suboptimal screening. It would be useful to
reduce the level of anxiety in these women.
Age seems to be an independent factor associated with
the use of screening. Mutation carriers younger than
40 years had a mammogram made less often than older
carriers (over 40 years) [7, 46]. In unaffected women at a
moderately increased risk for breast cancer and in whom no
DNA test was performed, the younger women also adhered
less to the mammography recommendations [3, 14, 29, 39].
On the other hand, others have reported that rates of
adherence to mammography were lower in women over
50 years [12, 22, 30].
Perceived risk is a predictor of both ovarian cancer
screening [22, 50, 58] and breast cancer screening [1, 3,
16], although women who perceived their risk as high were
less compliant with breast cancer screening recommenda-
tions [24, 43]. Although risk perception decreases after
genetic counseling, it is often still over-estimated, espe-
cially by cancer patients [47]. As this may affect screening
practices, efforts should be made to improve a patient’s
risk perception.
Family history predicts ovarian cancer screening [2, 22,
38, 52], but is related less to breast cancer screening
[3, 20]. This may be because ovarian cancer more often has
a fatal prognosis, which could motivate women to take
preventive measures.
Adherence to screening practices is associated with
recommendations from physicians [58]. The potential of
effective support from primary care physicians could be
utilized by involving them more in the surveillance of
women at high risk. Recommendations should be explicitly
communicated to primary physicians by general education.
In addition to training doctors, our findings also indicate a
need for better patient education about the screening
guidelines for high-risk women.
Prophylactic surgery
A patient’s decision to have prophylactic surgery may be
influenced by several physical and psychosocial factors.
Being a carrier of a BRCA1/2 mutation and the number of
affected relatives are major predictors of the decision to
have prophylactic surgery [49, 51], although Lerman et al.
[28] had opposite findings: the majority of the carriers in
their study did not opt for prophylactic surgery. On the
other hand, those who opted to have PM often had an
inaccurate perception of how high their risk for developing
breast cancer was, which emphasizes the importance of
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accurate risk counseling in women with a high risk for
breast and ovarian cancer. Cancer worry or anxiety was
also found to influence the choice for prophylactic surgery,
further underlining the importance of physicians providing
adequate information about cancer risk.
The tendency to have BPSO rather than PM may be
associated with the greater esthetic consequences of PM.
Moreover, women appear to prefer prophylactic surgery
more than early detection measures to reduce their risk for
ovarian cancer [7]. The fact that age was found to be a
strong predictor of oorophorectomy but not for mastectomy
may well be associated with future options for child-
bearing. Furthermore, especially young women with chil-
dren choose to have DNA testing and PM [36], which may
also be associated with subsequent decisions about having
children and their desire to see them grow up.
Another factor found to predict prophylactic surgery is
the physician’s advice and recommendations about it [51].
However, an important predictor of a patient later regret-
ting having had PM is when the physician was the one to
introduce this option into the discussion of treatment [6,
45]. This emphasizes that physicians must be well aware of
how much they may influence a woman’s decision to have
prophylactic surgery, and they must remain alert when
giving advice about possible treatment and monitoring
options and verify whether the choice for prophylactic
surgery is based on the patients’ own decision.
The uptake rates of PM and BPSO seem to differ
between different countries [28, 37]. Several studies sug-
gest cultural differences may also play a role in decision
making about prophylactic surgery [8, 18, 23]. Such cul-
tural differences are likely to be caused by different
attitudes of women at increased risk and their doctors and
substantial differences in the way cancer geneticists deal
with prophylactic surgery [8]. The adoption of national
guidelines for prophylactic surgery may increase homo-
geneity in surgery rates from country to country. However,
one must be aware of the cultural differences when
implementing international guidelines for families at risk
for breast and ovarian cancer.
Directions for future research
Most studies in this review had a retrospective and/or
cross-sectional design. Retrospective studies may be biased
by memory-bias and response-shift. Cross-sectional
designs disallow causal inferences between possible pre-
dictors and screening practices and the decision to have
prophylactic surgery. Future studies should preferably use
a prospective, longitudinal design to determine the pre-
dictors of screening behavior and prophylactic surgery.
Psychosocial assessment before genetic counseling in
women at high risk for breast or ovarian cancer, and at
several time-points afterwards, would provide information
about changes in women’s knowledge, risk perception,
cancer worries and distress, for example [11, 53, 56].
Screening for breast or ovarian cancer in women at risk
for these cancers may, in fact, be a burden leading to much
distress. Studies eligible for this review differed in their
definition of high risk. Most studies defined high risk as
having one first-degree relative with breast or ovarian
cancer, while a number of studies did not specify what they
defined as high risk (and these were not included in the
present review). Narod et al. [42] stated that high risk for
breast or ovarian cancer should be defined in future studies
as having at least two or more first-degree relatives with
this kind of cancer and/or being a mutation carrier. Many
studies selected for this review concerned women with a
moderate risk for breast or ovarian cancer, with only a few
studies covering women who were carriers of a BRCA
mutation. Future studies should therefore include only
women with a high risk for breast or ovarian cancer and/or
women who are mutation carriers.
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